Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial

Curran, Desmond; Pozzo, Carmelo; Zaluski, Jerzy; Dank, Magdalena; Barone, Carlo; Valvere, Vahur; YALÇIN, ŞUAYİB; Peschel, Christian; Wenczl, Miklos; GÖKER, ERDEM; Bugat, Roland

doi:10.1007/s11136-009-9493-z

Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial

Curran D., Pozzo C., Zaluski J., Dank M., Barone C., Valvere V., ...More

QUALITY OF LIFE RESEARCH, vol.18, no.7, pp.853-861, 2009 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 18 Issue: 7
Publication Date: 2009
Doi Number: 10.1007/s11136-009-9493-z
Journal Name: QUALITY OF LIFE RESEARCH
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.853-861
Open Archive Collection: AVESIS Open Access Collection
Hacettepe University Affiliated: Yes

Abstract

The quality of life (QL) of advanced gastric cancer patients receiving irinotecan, folinic acid and 5-fluorouracil (5-FU) (IF arm) or cisplatin with 5-FU (CF arm) is presented.